KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Operating Expenses (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Operating Expenses for 13 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 31.64% to $8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.4 million through Dec 2025, up 24.68% year-over-year, with the annual reading at $30.4 million for FY2025, 24.68% up from the prior year.
  • Operating Expenses hit $8.7 million in Q4 2025 for ClearPoint Neuro, up from $7.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $8.7 million in Q4 2025 to a low of $3.2 million in Q1 2021.
  • Historically, Operating Expenses has averaged $5.8 million across 5 years, with a median of $5.4 million in 2023.
  • Biggest five-year swings in Operating Expenses: soared 110.31% in 2021 and later decreased 13.34% in 2024.
  • Year by year, Operating Expenses stood at $5.0 million in 2021, then grew by 5.85% to $5.3 million in 2022, then rose by 1.3% to $5.4 million in 2023, then rose by 22.73% to $6.6 million in 2024, then soared by 31.64% to $8.7 million in 2025.
  • Business Quant data shows Operating Expenses for CLPT at $8.7 million in Q4 2025, $7.0 million in Q3 2025, and $7.2 million in Q2 2025.